Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesUniverse Pharmaceuticals Inc

Universe Pharmaceuticals Inc

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
1.495 USD 0.10 ( 7.55%)
Last update at 2026-11-09T15:42:00Z
VOLUME
7874
Market Cap
22.41M

Momentum Score

…

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. It also provides guben yanling, shenrong weisheng, and quanlu pill; yangxue danggui and qiangli pipa syrup; wuzi yanzong oral, fengtong medicinal, shenrong medicinal, qishe medicinal, fengshitong medicinal, and shiquan dabu medicinal liquor; paracetamol granule for children; and isatis root granule. In addition, the company distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. It primarily serves pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is headquartered in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
1.34
Low
1.50
High
52 Week Price Range
2.00
Low
17.96
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Universe Pharmaceuticals Inc is a NASDAQ-listed pharmaceutical company; publicly available information about its pipeline, revenues and operations is limited. Long-term growth may depend on clinical development progress, regulatory approvals, partnerships and successful commercialization, which could support value creation if achieved.
Material risks include sparse public disclosure, likely absence of meaningful revenue, high dependence on clinical and regulatory success, the need for external financing and dilution risk, and low market liquidity.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
1.39
Dividend Yield
-
Revenue TTM
17.74M
Revenue Per Share
31.48
Gross Profit TTM
6.48M
Debt / Equity
0.16
ROE
-3.51%
Net Debt
-24.34M
ROCE
-6.13%
Diluted EPS TTM
-1.28

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Type yearly yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Income before tax -3.67M -8.12M -3.94M -7.98M 13.68M
Net income -3.67M -8.73M -6.16M -8.74M 11.32M
Selling general administrative 4.21M 9.88M 2.22M 1.75M 3.30M
Selling and marketing expenses 3.80M - 6.78M 19.08M 2.97M
Gross profit 6.30M 6.07M 10.32M 21.89M 25.33M
Reconciled depreciation 0.52M 0.49M 0.51M 0.53M 0.45M
Ebit -3.44M -8.02M -3.69M -7.02M 13.59M
Ebitda -2.92M - -3.18M -6.40M 13.99M
Depreciation and amortization 0.52M - 0.51M 0.62M 0.40M
Operating income -2.92M -8.02M -3.53M -7.02M 13.59M
Other operating expenses 20.77M - 36.27M 47.16M 34.39M
Interest expense 0.23M 0.28M 0.16M 0.16M 0.10M
Tax provision 0.00M 0.61M 2.31M 0.75M 2.36M
Net interest income -0.23M -0.28M -0.16M -0.16M -0.10M
Income tax expense 0.61M - 2.25M 0.75M 2.36M
Total revenue 17.86M 23.02M 32.31M 40.14M 47.98M
Total operating expenses 9.22M 31.04M 13.84M 28.91M 11.74M
Cost of revenue 11.56M 16.95M 21.99M 18.25M 22.66M
Total other income expense net -0.76M 0.18M -0.41M -0.96M 0.09M
Net income from continuing ops -3.67M -8.73M -6.16M -8.74M 11.32M
Net income applicable to common shares - - - -8.74M 11.32M
Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Type yearly yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Total assets 69.30M 67.95M 53.29M 59.54M 70.14M
Intangible assets 0.30M 0.26M 0.15M 0.16M 0.18M
Other current assets 4.63M 0.85M 0.63M 1.72M 10.40M
Total liab 13.17M 22.45M 13.75M 13.10M 11.21M
Total stockholder equity 56.13M 45.50M 39.53M 46.44M 58.93M
Other current liab 1.57M - 3.69M 6.09M 1.57M
Common stock 6.34M - 0.07M 0.07M 0.07M
Capital stock 6.34M 0.48M 0.07M 0.07M 0.07M
Retained earnings -13.84M -10.17M 10.16M 16.32M 25.06M
Other assets - - - 12.92M 14.06M
Cash 33.59M 29.50M 5.29M 5.71M 8.08M
Total current liabilities 13.17M 20.31M 13.75M 13.10M 11.21M
Current deferred revenue 0.04M - - - -
Net debt -24.34M - 0.20M -1.78M -3.74M
Short term debt 9.26M - 5.48M 3.94M 4.33M
Short long term debt 9.26M 5.86M 5.48M 3.94M 4.33M
Short long term debt total 9.26M - 5.48M 3.94M 4.33M
Other stockholder equity 63.01M - 29.28M 29.28M 29.28M
Property plant equipment - - - 4.25M 4.68M
Total current assets 53.60M 51.64M 36.81M 41.51M 50.48M
Long term investments 0.70M 0.71M 0.69M 0.70M 0.74M
Net tangible assets - - - 46.28M 58.76M
Short term investments - - 13.22M 13.15M 13.73M
Net receivables 13.19M 12.91M 10.73M 15.18M 15.81M
Long term debt - 2.14M - - -
Inventory 2.19M 1.74M 3.34M 2.21M 2.46M
Accounts payable 1.67M 4.91M 4.59M 3.08M 5.31M
Accumulated other comprehensive income 0.63M - 0.03M 0.77M 4.53M
Non currrent assets other - - - 2.25M 2.48M
Non current assets total 15.70M 16.32M 16.48M 18.03M 19.66M
Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Type yearly yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Investments - -0.36M -0.04M -3.91M -13.53M
Change to liabilities - - - -1.90M 2.46M
Total cashflows from investing activities -0.34M - -0.04M -3.91M -27.06M
Net borrowings -5.27M 8.95M -1.39M 3.32M 0.62M
Total cash from financing activities 9.73M 33.95M -1.39M 3.32M 26.58M
Change to operating activities - - - 8.24M -7.81M
Net income -3.67M -8.73M -6.58M -8.74M 11.32M
Change in cash 4.09M 24.21M -0.43M -2.37M -1.98M
Begin period cash flow 29.50M 5.29M 5.71M 8.08M 10.06M
End period cash flow 33.59M 29.50M 5.29M 5.71M 8.08M
Total cash from operating activities -5.05M -9.51M 1.12M -1.31M -2.06M
Issuance of capital stock 15.00M 25.00M 0.00M 0.00M 28.75M
Depreciation 0.52M 0.49M 0.51M 0.53M 0.45M
Other cashflows from investing activities -0.08M - - - -10.63M
Dividends paid - - - 0.00M 0.00M
Change to inventory -0.47M 1.64M -1.18M 0.02M -0.45M
Change to account receivables 3.13M -1.55M 4.72M -1.55M -3.87M
Other cashflows from financing activities - - -3.09M 7.59M 1.51M
Change to netincome - - - 0.30M -1.14M
Capital expenditures 0.35M 0.36M 0.04M 0.09M 13.53M
Change in working capital -2.27M -2.06M 5.67M 6.59M -12.69M
Other non cash items 0.37M - -0.05M 0.91M -0.47M
Free cash flow -5.40M -9.87M 1.08M -1.41M -15.59M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
UPC
Universe Pharmaceuticals Inc		 0.10
7.55%		 1.50 - - 1.26 0.43 0.26 0.31
MKKGY
Merck KGaA ADR		 0.49
1.48%		 33.66 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 -2.76
1.62%		 167.12 24.86 15.11 3.13 1.98 3.08 18.89
TAK
Takeda Pharmaceutical Co Ltd ADR		 -0.05
0.24%		 20.97 - 10.96 0.01 1.20 2.94 23.11
TKPHF
Takeda Pharmaceutical Co. Ltd.		 0.50
1.19%		 42.35 - 10.66 0.01 1.16 2.94 23.11

Profile*

Universe Pharmaceuticals Inc

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. It also provides guben yanling, shenrong weisheng, and quanlu pill; yangxue danggui and qiangli pipa syrup; wuzi yanzong oral, fengtong medicinal, shenrong medicinal, qishe medicinal, fengshitong medicinal, and shiquan dabu medicinal liquor; paracetamol granule for children; and isatis root granule. In addition, the company distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. It primarily serves pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is headquartered in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.

265 Jingjiu Avenue, Ji'An, China, 343100

86 79 6840 3309

https://www.universe-pharmacy.com

216

Name Title Year Born
Mr. Gang Lai CEO & Chairman 1967
Ms. Lin Yang CFO & Director 1976
Mr. Baochang Liu Chief Operating Officer 1980
Mr. Gang Lai CEO & Chairman 1968
Mr. Baochang Liu Chief Operating Officer 1981

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

GFR
CAD 10.96
+38.15%
MOON
CAD 4.83
+9.64%
PDN
CAD 8.13
+7.68%
BDT
CAD 72.82
+6.65%
HG
CAD 4.28
+6.20%
CSU
CAD 3300.00
-6.42%
CURA
CAD 12.68
-4.16%
DIV
CAD 3.93
-3.44%
SOIL
CAD 7.18
-3.10%
OBE
CAD 13.31
-2.92%

Equity Sectors*

  • Basic Materials

    +3.19%

  • Communication Services

    -0.04%

  • Consumer Cyclical

    +0.27%

  • Consumer Defensive

    -0.21%

  • Energy

    +1.16%

  • Financial Services

    +0.81%

  • Healthcare

    +0.03%

  • Industrials

    +1.64%

  • Real Estate

    +0.06%

  • Technology

    +0.38%

  • Utilities

    +0.68%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…